The Epithelial–Stromal Microenvironment in Early Colonic Neoplasia

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Molecular Cancer Research

• Publication date

  2021-10-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1541-7786.MCR-21-0202PMID 34670862PMCID PMC8738147
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CCL22 Signaling in the Tumor Environment.

  2020cited by this paper
• Limiting oxidative DNA damage reduces microbe-induced colitis-associated colorectal cancer

  2020cited by this paper
• CXCL13/CXCR5 signaling axis in cancer.

  2019cited by this paper
• Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy.

  2019cited by this paper
• CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodes

  2019cited by this paper
• Senescence‐associated tissue microenvironment promotes colon cancer formation through the secretory factor GDF15

  2019cited by this paper
• CXCL13 and Its Receptor CXCR5 in Cancer: Inflammation, Immune Response, and Beyond

  2019cited by this paper
• CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions.

  2018cited by this paper
• CCR7 mediates human breast cancer cell invasion, migration by inducing epithelial–mesenchymal transition and suppressing apoptosis through AKT pathway

  2017cited by this paper
• Proximal Aberrant Crypt Foci Associate with Synchronous Neoplasia and Are Primed for Neoplastic Progression

  2017cited by this paper
• Genome-wide DNA methylation profiling reveals cancer-associated changes within early colonic neoplasia

  2017cited by this paper
• CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironment

  2016cited by this paper
• Distinct Transcriptional Changes and Epithelial–Stromal Interactions Are Altered in Early-Stage Colon Cancer Development

  2016influential reference
• Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironment

  2016cited by this paper
• B-RAF mutation and accumulated gene methylation in aberrant crypt foci (ACF), sessile serrated adenoma/polyp (SSA/P) and cancer in SSA/P

  2014cited by this paper
• HD Chromoendoscopy Coupled with DNA Mass Spectrometry Profiling Identifies Somatic Mutations in Microdissected Human Proximal Aberrant Crypt Foci

  2014cited by this paper
• Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

  2014cited by this paper
• CRTAM controls residency of gut CD4+CD8+ T cells in the steady state and maintenance of gut CD4+ Th17 during parasitic infection

  2014cited by this paper
• Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence.

  2011cited by this paper
• S100A8 and S100A9: New Insights into Their Roles in Malignancy

  2011cited by this paper
• Up and downregulation of p16Ink4a expression in BRAF-mutated polyps/adenomas indicates a senescence barrier in the serrated route to colon cancer

  2011cited by this paper
• CXCR4 and cancer

  2010cited by this paper
• PD-1 and its ligands in tolerance and immunity.

  2008cited by this paper
• Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network.

  2008cited by this paper
• Mutations in BRAF and KRAS differentially distinguish serrated versus non-serrated hyperplastic aberrant crypt foci in humans.

  2007cited by this paper
• CCR7 mediates inflammation-associated tumor progression

  2006cited by this paper
• Rectal Aberrant Crypt Foci Identified Using High-Magnification-Chromoscopic Colonoscopy: Biomarkers for Flat and Depressed Neoplasia

  2005cited by this paper
• p16(INK4a) expression begins early in human colon neoplasia and correlates inversely with markers of cell proliferation.

  2000cited by this paper
• Identification of PECAM-1 in solid tumor cells and its potential involvement in tumor cell adhesion to endothelium.

  1993cited by this paper

• The immune microenvironment of colorectal cancer

  2025cites this paper
• Identification of biomarkers for the diagnosis in colorectal polyps and metabolic dysfunction-associated steatohepatitis (MASH) by bioinformatics analysis and machine learning

  2024cites this paper
• Landscapes and mechanisms of CD8+ T cell exhaustion in gastrointestinal cancer

  2023cites this paper
• Comprehensive proteomic signature and identification of CDKN2A as a promising prognostic biomarker and therapeutic target of colorectal cancer

  2022cites this paper